Needs Assessment of Long-Term Care for Psychiatric Patients
NCT00172887 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1150
Last updated 2007-10-23
Summary
The quantity and quality of inpatient services for persons with psychiatric illness have been enhanced in the last two decades. Following the enforcement of nationwide health insurance and the Physically and Mentally Disabled Citizens Protection Act, the financial pressure of medical care for psychiatric patients is relieved, and actions related to the protection of patients' human rights have been taken. Nonetheless, problems related to psychiatric illness are not limited to symptoms. Patients' daily functions are affected and it causes continuous pressure on the family. Currently, psychiatric care places more emphasis on inpatient services. Once the patient is discharged from the hospital, related psychiatric services are not widely available, which leads to symptom exacerbation, repeated hospital admissions, increased burden to the family, etc. A provision of continuous long-term care that meets the various needs of psychiatric patients is a critical issue in current psychiatric care.
Based on a three-phase needs assessment model, the purpose of the study is to evaluate the needs of long-term care for psychiatric patients. The first phase will identify the current status of needs from the perspectives of patients and the family, psychiatric professionals, and the system. The second phase will identify the goals of long-term care for psychiatric patients. The goals will be identified by a nominal group, composed of experts related to the field of psychiatric long-term care. The third phase will determine the objectives of long-term care services for psychiatric patients. That is to determine the proper contents of long-term care services for the patients based on the goals identified in the previous phase.
The three-phase needs assessment will be carried out in a two-year period. The results of the study will provide important information to the future planning of long-term care for psychiatric patients.
Conditions
- Mental Disorders
Sponsors & Collaborators
-
Department of Health, Executive Yuan, R.O.C. (Taiwan)
collaborator OTHER_GOV -
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chinyu Wu, Ph.D · Department of Occupational Therapy, National Taiwan University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-03-31
- Completion
- 2005-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853 ·Status: RECRUITING ·Phase: PHASE2
-
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895 ·Status: RECRUITING ·Phase: PHASE2
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan
NCT01170689 ·Status: COMPLETED
-
Current Trend of Epidemiology of Psychiatric Emergency and the Stress of Duty Psychiatric Resident
NCT03539471 ·Status: UNKNOWN
-
Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
NCT07192042 ·Status: RECRUITING
-
Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia
NCT05304780 ·Status: COMPLETED ·Phase: NA
-
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445 ·Status: UNKNOWN ·Phase: NA
-
Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
NCT03329287 ·Status: UNKNOWN ·Phase: NA
-
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
NCT00797927 ·Status: COMPLETED ·Phase: PHASE4
-
Research on Accurate Prediction of Long-term Medication Use for Schizophrenia Based on Cognitive Function
NCT04513275 ·Status: UNKNOWN
-
Epigenetic Regulation of BDNF in Schizophrenia
NCT01021449 ·Status: COMPLETED
-
Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia
NCT02001103 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954 ·Status: COMPLETED ·Phase: NA
-
Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers
NCT02868307 ·Status: UNKNOWN ·Phase: NA
-
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893 ·Status: COMPLETED
-
Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
NCT05159349 ·Status: RECRUITING
-
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group
NCT03965598 ·Status: UNKNOWN
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Neuroendocrine and Metabolite Substrates in Schizophrenia
NCT02423096 ·Status: UNKNOWN
-
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
NCT05835583 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Redesign For Schizophrenia
NCT04430868 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients
NCT00423033 ·Status: COMPLETED
-
Antipsychotic Discontinuation in High-risk Subjects
NCT01758887 ·Status: WITHDRAWN